Rotterdam-based HealthTech startup Ditto has successfully secured €7.6 million in a funding round to fuel its European expansion. The company developed an AI-powered application designed to translate complex medical information into understandable language for patients. The investment was led by Heal Capital, with notable participation from Optiverder and Rubio Impact Ventures.
Empowering Patients Through Clear Communication
Ditto addresses a common challenge where patients leave consultations feeling uncertain and unable to recall crucial details. The app allows users to record conversations with doctors or photograph medical letters for processing. Within minutes, it generates a clear, structured summary, helping to eliminate confusion and improve patient comprehension.
The platform is designed to put control back into the hands of the patient, offering features like translation into English, Turkish, or Arabic. This functionality ensures that language barriers do not hinder a patient's understanding of their own health. By simplifying medical jargon, the app helps individuals and their families make more informed decisions about their care.
Rapid Growth and Industry Recognition
Since its launch last summer, the application has demonstrated significant market traction, attracting nearly 100,000 users. This rapid adoption is supported by endorsements from key industry players, including the Dutch Patients' Federation. Furthermore, health insurer Menzis has begun recommending the app to all its policyholders, validating its utility.
The company's innovative approach has also earned formal accolades, recently winning the 2026 Dutch National Healthcare Innovation Award. This recognition underscores Ditto's impact on improving the patient experience and its potential to innovate within the healthcare sector. The award highlights the growing demand for patient-centric technology solutions that bridge communication gaps.
Investor Confidence in a Patient-First Model
Investors have expressed strong confidence in Ditto's unique focus on the patient rather than the practitioner. Dr. Lucas Mittelmeier of Heal Capital noted that while many startups build AI for doctors, Ditto's patient-equivalent has clearly resonated with the market. He believes the platform is poised to become the European standard for navigating healthcare.
Co-founder Tobias Polak emphasized the company's mission to fundamentally shift healthcare thinking to a patient-first perspective. He envisions a future where understanding one's care journey is as simple as using a navigation app. This ambition for accessible and clear healthcare information is a core driver of the company's strategy.
Expansion Plans and Data Privacy Commitment
The new capital will be strategically deployed to expand Ditto's presence across Europe and introduce new features. These enhancements will further support patients and their families, offering tools like pre-consultation question guides and a visual care journey. The goal is to provide comprehensive support throughout the entire healthcare process.
Ditto maintains a strong commitment to data security through a privacy-by-design approach, ensuring user information remains secure. The company does not store medical data on its servers after processing and utilizes EU-based infrastructure for all operations. This GDPR-compliant framework ensures that sensitive health information never leaves the user's device without their consent.
This €7.6 million investment marks a pivotal moment for Ditto, enabling the company to scale its innovative solution across Europe. By empowering patients with clarity and control over their medical information, the startup is set to redefine the patient experience. The funding will accelerate its mission to make healthcare navigation intuitive and accessible for everyone.